{
}
The Centers for Medicare and Medicaid Services proposed a rule to cover obesity drugs under Medicare and Medicaid starting in 2026, potentially benefiting 3.4 million people at a cost of $25 billion over ten years. This historic move reclassifies obesity drugs as treatments for chronic disease, aligning with medical consensus on obesity's health risks. Additionally, the rule aims to enhance transparency in Medicare Advantage plans and improve access to health services.
In a potential second Trump administration, health care policy will likely focus on regulatory reform, including unwinding Biden-era regulations and emphasizing the "Make America Healthy Again" agenda. Key issues will include opposition to the Affordable Care Act, drug pricing reforms, and addressing the opioid crisis, alongside a commitment to domestic medical supply chains. The administration is expected to leverage budget reconciliation and appropriations to shape health policy amidst a challenging legislative environment.
Robert F. Kennedy Jr., an environmental lawyer and vaccine skeptic, has been nominated as the next Secretary of Health in the Trump II administration. His controversial views include unsubstantiated claims linking vaccines to autism and promoting conspiracy theories about HIV and antidepressants. Kennedy aims to reform health agencies by eliminating corporate influence and restoring evidence-based practices.
Sage Therapeutics is restructuring, cutting about one-third of its workforce, which amounts to approximately 165 employees, primarily in research. The company is also reprioritizing its drug pipeline following setbacks, including mixed results for its drug Zurzuvae and failures in trials for other neurological treatments. Sage aims to extend its operating runway while focusing on launching Zurzuvae, which has seen a gradual increase in prescriptions.
Lexicon Pharmaceuticals has sold the rights to its cardio drug, sotagliflozin, to Viatris for $25 million upfront, with potential milestone payments of up to $200 million. This move comes as Lexicon restructures and aims to expand into Type 1 diabetes, with an FDA advisory panel set to review the drug's use in this area on October 31. The approval could unlock a $400 million U.S. market for the drug, which is currently marketed as Inpefa for heart failure and related conditions.
Food and Drug Administration
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
medicare and medicaid to cover obesity drugs starting in 2026
United States Dollar
Food and Drug Administration
USA
Julia Burmistrova
Meena Seshamani
Daniel M. Tsai
Show more
17:59 26.11.2024
trump administration health policy priorities and challenges in second term
01:00 21.11.2024
Robert F Kennedy Jr appointed as Health Secretary in Trump administration
Centers for Disease Control and Prevention
Food and Drug Administration
Centers for Medicare and Medicaid Services
Donald Trump
Robert Kennedy Jr
Show more
16:10 15.11.2024
sage therapeutics lays off one third of workforce amid restructuring efforts
14:08 17.10.2024
lexicon sells rights to cardio drug to viatris amid restructuring efforts
United States Dollar
Eli Lilly and Company
Viatris Inc.
Food and Drug Administration
Jefferies Financial Group Inc.
Lexicon Pharmaceuticals, Inc.
USA
Jeff Wade
Andrew Tsai
Show more
13:15 17.10.2024
Trending
Subcategory
Industry Trends
Corporate News
Startups & Entrepreneurship
Global Trade Developments
Government Economic Policies
Retail and Consumer Goods
Supply Chain Management
Industry Mergers & Acquisitions
Stock Market Updates
Energy Sector Developments
Venture Capital Investments
Global Financial Events
Finance Mergers & Acquisitions
Central Bank Actions
Cryptocurrency & Blockchain Regulations
Emerging Startups
Funding Rounds & Investments
Inflation and Monetary Impact
Private Equity Deals
Market Analysis and Predictions
Countries:
Companies:
Apple Inc.
NVIDIA Corporation
Google Inc.
Dell Technologies Inc.
Samsung Securities Co.,Ltd.
Learning Resources Inc.
MGA Entertainment Inc.
XPeng Inc.
Toyota Motor Corp
State Street Global Advisors Luxembourg SICAV - SSGA EMU ESG Screened Equity Fund
European Union Bonds
Taiwan Semiconductor Manufacturing Company Limited
Microsoft Corporation
Verizon Communications Inc.
OpenAI ERC USD
SLB 4,6% 01JUN25
Equinor Ventures AS
Quanta Services, Inc.
Gold Circuit Electronics Ltd.
Unimicron Technology Corp.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
Australian Dollar
United Arab Emirates Dirham
British Pound Sterling
New Taiwan Dollar
New Zealand Dollar
Vietnamese Đồng
South Korean Won
Egyptian Pound
Thai Baht
Saudi Riyal
Indonesian Rupiah
South African Rand
Malaysian Ringgit
Singapore Dollar
Lebanese Pound
People: